Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory diffuse large B-cell lymphoma: Updated results of a phase Ib/II randomized study and preliminary results of a single-arm extension Meeting Abstract
| Authors: | Sehn, L. H.; Hertzberg, M.; Opat, S.; Herrera, A. F.; Assouline, S. E.; Flowers, C.; Kim, T. M.; McMillan, A.; Ozcan, M.; Safar, V.; Salles, G.; Musick, L.; Hirata, J.; Chang, Y.; Ku, G.; Matasar, M. J. |
| Abstract Title: | Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory diffuse large B-cell lymphoma: Updated results of a phase Ib/II randomized study and preliminary results of a single-arm extension |
| Meeting Title: | 62nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 136 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Dec 5-8 |
| Meeting Location: | Virtual |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2020-11-05 |
| Language: | English |
| ACCESSION: | WOS:000607205606040 |
| DOI: | 10.1182/blood-2020-137078 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 17 -- Source: Wos |
